Kyle Dempsey, MD, MBA, is a Partner at MVM Partners, a healthcare-focused private equity firm based in Boston. See sector focus and contact routes.
Kyle Dempsey, MD, MBA, is a Partner at MVM Partners, a healthcare-focused private equity firm based in Boston, where he joined in 2017 after working as a healthcare consultant at Bain & Company. His investment focus centers on commercial-stage healthcare and life science companies, leveraging his background in medicine and business to evaluate opportunities in the sector. While specific check sizes and lead/follow behavior are not publicly detailed, his role involves active investing in life sciences venture capital and growth equity. Dempsey holds board director positions at notable portfolio companies including Optinose, Inc. (NASDAQ:OPTN), GT Medical Technologies, Inc., and serves as a board observer for MDxHealth SA (NASDAQ:MDXH). He also serves as an independent director on the board of HLS Therapeutics Inc.. Dempsey is recognized as a prolific researcher and writer who published peer-reviewed papers on genetics and orthopedic surgery outcomes during his academic training, though no recent public investment commentary or distinctive point of view is documented in available sources.
This profile is part of the StartupFundraising investor database: focus, portfolio history, disclosed location and contact routes, refreshed as new filings and rounds are ingested. Founders use it to check fit before reaching out and to find investors in Boston.
Investors like Kyle Dempsey · Full investor directory · Investor access · Company funding database